Posts tagged “Venture & Innovation”

Updated July 11, 2007

Premium Lock Semiconductor Startup Semprius Lands New Investor

 UPDATE: Durham-based firm adds $500,000 to the $4.7M in Series A funding it announced in April.

July 11, 2007

Premium Lock Startup Tikvah Therapeutics Closes on $10M

Tikvah Georgia-based firm seeks new treatments for already approved drugs with emphasis on nervous system disorders.

July 10, 2007

Premium Lock Georgia Biotech Company Lands First Venture Financing

Abeome Abeome, which has licensed antibody technology from University of Georgia, has also received $200,000 in grants.

July 9, 2007

Premium Lock UNCW Professor, Venture Capitalist to Co-Chair Opportunity Conference

 Fifth annual event from CED is set for Sept. 10-11 in Wrightsville Beach, N.C.

Updated July 9, 2007

Premium Lock Battery Ventures Closes on $750M Fund

venture capital logo Venture capital firm, with offices in Massachusetts and Silicon Valley, has several investments in southeast.

July 6, 2007

Premium Lock NephroGenex Closes on $3.3M in New Financing

NephroGenex Cary-based firm has licensed drug candidate from BioStratum that could be treatment for kidney disease.

July 3, 2007

Premium Lock Looking for Angel Funding? Here’s How …

venture capital logo The 10 secrets to approaching angel investors.

July 2, 2007

Premium Lock Innovation Focus: An Entrepreneur’s Perspective on Relocating to the Triangle

CED Entrepreneurial Spirit: Access to capital, talent, quality life and fellow entrepreneurs makes region attractive, says CEO of firm that chose to move to Triangle.

June 29, 2007

Premium Lock Deadline Nears for Firms to Apply for SEBIO Venture Event

SE BIO Southeast BIO Conference is set for Nov. 7-8 in Pinehurst.

Updated June 29, 2007

Premium Lock Contacting Dollar$: E-mail Marketing Firm iContact Lands $5.35M

iContact's Aaron Houghton, left, and Ryan Allis. Durham-based startup looks to nearly double staff. Updata Partners leads round. IDEA Fund Partners also participates.

June 28, 2007

Premium Lock Triangle Execs Head to Boston Looking for Ca$h

CED CED, Research Triangle Regional Partnership send delegation of private, public sector execs to northeast for meeting with potential investors.

Updated June 28, 2007

Premium Lock Oversubscribed Round: Serenex Lands $31M in New Financing

 Four new investors join Intersouth, other previous firms in oversubscribed ‘D’ round. Of amount, $5 million is for working capital debt facility.

June 27, 2007

Premium Lock Constella Group’s Selling Price: $185 Million

Constella Group SRA International to pay off $46M in debt as part of deal for Durham consulting firm.

Updated June 27, 2007

Premium Lock Georgia Firm Secures $7M in New Financing to Battle Cellulite

Cellutions Cellutions is developing device, procedure for ‘lunchtime’ treatment of cellulite in women.

June 27, 2007

Premium Lock Oncology Device Startup Raises $800,000 in Financing

venture capital logo CivaTech, launched by two execs who helped start Sicel Technologies, is developing implantable radiation device to treat prostate cancer.

Updated June 26, 2007

Premium Lock EG Technology Closes on Another $5M in Funding

EG Technologies Noro-Moseley, other existing investors participate in addition ‘C’ round funding.

June 26, 2007

Premium Lock The Google of Video? Digitalsmiths Closes on $6M

Ben Weinberger, left, and Matthew Berry Aurora Funds, Chrysalis Ventures, individuals back play of digital video search, demographic startup. Company recently relocated to Triangle from South Carolina.

Updated June 26, 2007

Premium Lock Two University Spinouts Receive $50,000 Loans, Support from N.C. Biotech Center

NC Biotech Center New programs are designed to give boost to technology transfer efforts.

June 26, 2007

Premium Lock Innovation Focus, Part 2: Nurturing a Culture of Entrepreneurship in Research Triangle

Monica Doss Growth, capital, globalization present challenges, opportunities in coming years.

Updated June 25, 2007

Premium Lock Going South: Intersouth Targets Argolyn Bioscience for Financing

 update: Intersouth Partners, Quaker BioVentures co-lead $15.8M round for South Carolina-based drug development firm. Argolyn targets pain, psychosis with first two candidates. Deal is Intersouth’s first in S.C.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith